The advent of recombinant technology has dramatically altered the landscape of cytokine research, allowing for the precise production of specific molecules like IL-1A (also known as IL-1α), IL-1B (IL-1β), IL-2 (interleukin-2), and IL-3 (interleukin-3). These engineered cytokine sets are invaluable resources for researchers investigating host resp